Log In
BCIQ
Print this Print this
 

CBP501

  Manage Alerts
Collapse Summary General Information
Company CanBas Co. Ltd.
DescriptionSynthetic duodecapeptide that inhibits cell cycle progression by blocking DNA repair at the G2 checkpoint
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today